UnitedHealth Group (UNH)

Buffett's recent actions tell us something extremely important about the market right now.

Warren Buffett's Berkshire Hathaway has once again sent ripples through the financial markets with its latest Q3 2025 13F filing, released on November 14, 2025. The filing revealed a continuation of the conglomerate's cautious stance, marking a twelfth consecutive quarter of net stock sales and an unprecedented accumulation of cash,

UnitedHealth Group raised its dividend in each of the last 16 years.

The latest Job Openings and Labor Turnover Survey (JOLTS) data, released on December 9, 2025, for the month of October, presents a nuanced picture of the U.S. labor market. While a slight uptick in job openings might offer a glimmer of resilience, the overarching trends of stagnant hiring and

JPMorgan Chase & Co. (NYSE: JPM), a titan of the financial industry and a significant component of the Dow Jones Industrial Average (DJIA), recently experienced a notable shift in market sentiment. Despite a year of robust financial performance characterized by surging earnings and revenue growth throughout 2024 and 2025, a cautious

New York, NY – December 8, 2025 – A recent report from the Federal Reserve Bank of New York (New York Fed) reveals a concerning trend: U.S. households are growing increasingly pessimistic about their financial situations, even as inflation expectations remain largely stable. Released today, the November 2025 Survey of Consumer

UNH shares slipped below their 50-day moving average on October 31 and have remained below the mark so far.

Income investors should like these three Buffett stocks, along with three other honorable mentions.

Despite having one foot out the door, Berkshire Hathaway's billionaire boss is still positioning his company for long-term success.

Buffett might be worried about the valuations of stocks today.

The new year should be a happier one for this beleaguered healthcare giant.

With Salesforce sinking while the Dow climbs this year, is CRM stock a rare blue-chip bargain or a trap in disguise?

One pundit following the company envisions notable improvements in both UnitedHealth and Optum.

The health insurance giant's stock got a big boost after Wall Street learned Berkshire Hathaway had invested in it.

Shares of health insurance company UnitedHealth (NYSE:UNH) jumped 4.5% in the afternoon session after a flurry of positive analyst actions and strategic company updates signaled confidence in the healthcare giant's direction. Multiple firms expressed optimism, with Wolfe Research lifting its price target to $375 from $330. Bernstein also boosted its target to $440, and RBC Capital raised its target to $408. This positive sentiment was reportedly tied to the belief that UnitedHealth was positioned to improve its profit margins within its insurance division.

The U.S. private sector delivered an unexpected blow to economic optimists in November 2025, with payrolls contracting by a surprising 32,000 jobs. This significant downturn, reported by payroll processing firm ADP, defied economists' expectations for modest growth and immediately sent ripples through financial markets. The sudden slowdown intensifies

Management is hopeful that its adjustments will work to improve profits in 2026.

Wall Street has recently concluded a tumultuous yet ultimately resilient period, with the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite all managing to edge higher in late November and early December 2025. This cautious comeback signals a complex market sentiment, where investors are meticulously weighing the promise

The company is trying to get back on track after a tumultuous year.

UnitedHealth sells Banmedica for $1 billion to Patria Investments, completing its Latin America exit as the company presses ahead with a multi-year turnaround.

UnitedHealth acquired the Chilean company for $2.8 billion in 2018.